Search for a command to run...
Albert David Ltd. is currently positioned in a challenging space with stagnant growth, but comparisons with its peers reveal several outperformers, especially in profitability and growth metrics. Companies like Mankind Pharma and Dr. Reddy's show strong potential. While Albert David has low valuations, it lacks growth and profitability metrics, making it less attractive.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
ALBERTDAVD | ₹814.70 | ₹464.96Cr | 27.03 | - | - |
SUNPHARMA | ₹1,563.35 | ₹3,75,099.26Cr | 87.59 | 17.60% | 0.04 |
DIVISLAB | ₹6,091.05 | ₹1,61,698.50Cr | 73.20 | 16.46% | - |
CIPLA | ₹1,587.60 | ₹1,28,217.27Cr | 23.73 | 22.77% | 0.01 |
TORNTPHARM | ₹3,581.55 | ₹1,21,215.77Cr | 61.53 | 24.28% | 0.57 |
DRREDDY | ₹1,280.30 | ₹1,06,835.27Cr | 15.50 | 26.86% | 0.07 |
MANKIND | ₹2,518.95 | ₹1,03,926.59Cr | 55.18 | 28.38% | 0.02 |